SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

 Division of Infectious Diseases

[Return To Index page]
photo Brian Potoski, PharmD, BCPS

Associate Director, Antibiotic Management Program, Div Infectious Diseases

Email: potoskiba@upmc.edu

Phone: 412-648-6487

Contact
Office: Falk Medical Building, Suite 3A
3601 Fifth Avenue
Pittsburgh, PA 15213
 
Phone: 412-648-6487
Fax: 412-648-6399
E-mail: potoskiba@upmc.edu
Administrative Assistant:
Mary Ann Brown
Address: Falk Medical Bldg.
3601 Fifth Ave., Suite 3A
Pittsburgh, PA 15213
Email: mab403@pitt.edu
Phone: 412-648-6273
Fax: 412-648-6399
Education and Training
Education
Doctor of Pharmacy, University of PIttsburgh, School of Pharmacy, 1999
Training
Pharmacy Practice Residency, Ohio State University Medical Center, 2001
Infectious Diseases Pharmacy Residency, Ohio State University Medical Center, 2002
Research Interest
Dr. Potoski's research interests center on antimicrobial stewardship. Additionally, he is interested in how Monte Carlo simulations of antibiotic exposures may inform dosing strategies for problematic pathogens. Dr. Potoski also is interested in how risk factor studies may assist antibiotic management teams and the impact of antibiotic management teams on drug use and clinical outcomes.
Clinical Interest
The application of multidisciplinary antimicrobial stewardship teams within health-systems to improve patient outcomes and the associated impact on bacterial susceptibility rates and antibiotic longevity.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Wong A, Pickering AJ, Potoski BA. Dosing practices of intravenous acyclovir for herpes encephalitis in obesity: results of a pharmacist survey. J Pharm Pract. 2016; Apr 10.
Buehrle DJ, Shields RK, Chen L, Hao B, Press EG, Alkrouk A, Potoski BA, Kreiswirth BN, Clancy CJ,, Nguyen MH. Evaluation of the in vitro activity of ceftazidime-avibactam and ceftolozane-tazobactam against meropenem-resistant Pseudomonas aeruginosa isolates. Antimicrob Agents Chemother. 2016; 22: 3227-31.
Eschenauer GA, Kwak EJ, Humar A, Potoski BA, Clarke LG, Shields RK, Abdel-massih R,, Silveira FP, Vergidis P, Clancy CJ, Nguyen MH. Targeted versus universal prophylaxis among liver transplant recipients. Am J Transplant. Am J Transplant. 2015; 15: 180-9.
Pogue JM, Potoski BA, Postelnick M, Mynatt RP, Trupaino DP, Eschenauer GA, Kaye KS. Bringing the “Power” to Cerner’s Powerchart for Antimicrobial Stewardship. Clin Infect Dis. 2014; 59: 416-24.
Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, Polsky B, Adams-Haduch JM,, Doi Y. Treatment Outcome of Bacteremia due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens. Antimicrob Agents Chemother. 2012; 56: 2108-13.
Notable Achievements
Recipient, Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy. Awarded by the Society of Infectious Diseases Pharmacists (SIDP), 2013